Literature DB >> 4017597

Complications after overdose with tricyclic antidepressants.

T A Stern, P T O'Gara, A G Mulley, D E Singer, G E Thibault.   

Abstract

We reviewed 72 consecutive cases of tricyclic antidepressant (TCA) overdose (OD) admitted from the emergency ward (EW) to the ICU between 1977 and 1982. Most patients were seriously ill before ICU admission: 70% were comatose; 68% were intubated, including 61% in need of mechanical ventilation; and 30% were hypothermic. One patient died after ICU admission. ECG abnormalities were present in 37 (51%) patients in the EW. These abnormalities were associated with higher TCA plasma levels, but not with either acidosis or hypoxemia. Of 14 patients without ECG abnormalities or the need for intubation in the EW, none developed new ECG abnormalities or required ventilatory support. No patient had a late complication after transfer from the ICU, after a mean stay of 2.1 days. Late, unexpected complications in TCA OD are very rare. Our study suggests that TCA OD patients who do not have an abnormal ECG and do not require ventilatory support at the time of initial evaluation may not need ICU admission simply for intensive observation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017597     DOI: 10.1097/00003246-198508000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Near fatal case of atrio-ventricular block induced by amitriptyline at therapeutic dose.

Authors:  A Lappa; A Castagna; C Imperiale; M Fenga
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

2.  Emergency medicine: evaluating patients with tricyclic antidepressant overdose for risk of complications.

Authors:  G E Foulke; M Callaham
Journal:  West J Med       Date:  1987-05

3.  The triage decision in pulmonary edema.

Authors:  M H Katz; B W Nicholson; D E Singer; P A Kelleher; A G Mulley; G E Thibault
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.